Unknown OBSERVATIONAL NCT04927520

Prospective, Multicenter Cohort Study on the Safety and Efficacy of Treatment for Middle Cerebral Artery Aneurysms

Safety and Efficacy of Treatment for Middle Cerebral Artery Aneurysms: a Prospective and Multicenter Trial

Sponsor: First Affiliated Hospital of Wenzhou Medical University

Conditions Middle Cerebral Artery Aneurysm

Updated 4 times since 2021 Last updated: Jun 14, 2021 Started: Jun 5, 2021 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04927520, this observational or N/A phase trial focuses on Middle Cerebral Artery Aneurysm and remains ongoing. Sponsored by First Affiliated Hospital of Wenzhou Medical University, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Feb 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2021 — Jul 2024 [monthly]

Recruiting

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

First Affiliated Hospital of Wenzhou Medical University
Jinhua Central Hospital
Ningbo No. 1 Hospital
People's Hospital of Quzhou
Second Affiliated Hospital, School of Medicine, Zhejiang University
Taizhou Hospital
The Central Hospital of Lishui City

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China